- Vanda Pharmaceuticals (VNDA -0.9%) reports that it has reached agreement with the German National Association of Statutory Health Insurance Funds on the price of HETLIOZ (tasimelteon) for the treatment of non-24-hour sleep-wake disorder.
- The ex-factory price, based on an Arbitration Board decision, will be €69K per year, effective August 1.
Price of Vanda's Hetlioz set at €69K in Germany
Recommended For You
More Trending News
About VNDA Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
VNDA | - | - |
Vanda Pharmaceuticals Inc. |